 |
市场调查报告书
商品编码
1481941
到 2030 年北美鱼疫苗市场预测 - 区域分析 - 按疫苗类型、应用、给药途径和物种North America Fish Vaccines Market Forecast to 2030 - Regional Analysis - by Vaccine Type, Application, Route of Administration, and Species |
||||||
2022年北美鱼疫苗市场估值为1.6022亿美元，预计2030年将达到2.6807亿美元；预计2022年至2030年复合年增长率为6.6%。
政府发展水产养殖业的措施推动北美鱼疫苗市场
由于对海鲜的高需求和野生鱼类年捕捞量的减少，水产养殖呈指数级增长。因此，各国政府正采取措施改善和支持水产养殖业的发展。以下是最近的一些倡议：
2021 年 2 月，食品与农业研究基金会 (FFAR) 资助 790,326 美元创建疫苗输送系统，帮助阻止罗非鱼湖病毒和其他疾病在水产养殖领域的传播。
Sea Grant 海洋水产养殖补助计划：这项全国性的竞争性补助计划，正式名称为“国家海洋水产养殖计划 (NMAI)”，旨在促进研究和示范计划，以推动美国可持续海水养殖。
NOAA 小型企业创新研究 (SBIR) 计画：NOAA 的 SBIR 计画促进小型企业利用联邦资金投资尖端技术以及可实现商业化的下一代产品和流程，支持对水产养殖研究和开发的投资。
其他一些计划包括 NOAA 渔业融资计划、海洋渔业倡议 (MARFIN) 和其他区域试点项目。
2022 年，美国农业部国家食品和农业研究所 (NIFA) 宣布投资超过 1,300 万美元，用于研究动物疾病的新疗法和预防措施，这些疾病给全球农业部门带来了数十亿美元的损失。其中包括向密西西比州立大学拨款 625,000 美元，用于评估一种抗菌饲料添加剂，该添加剂可用于以安全有效的方式预防鲶鱼肠败血症。这项研究将有助于开发水产养殖生产者的处理替代方案，并提高生产效率。
因此，政府支持水产养殖业发展的倡议的增加推动了鱼疫苗市场的成长。
北美鱼疫苗市场概况
北美鱼疫苗市场分为美国、加拿大和墨西哥。该地区的市场成长归因于水产养殖业的成长和对水生动物性食品的需求激增。据美国国家海洋和大气管理局称，美国水产养殖每年创收约 15 亿美元。根据世界银行的数据，美国生产了约 44.8 万吨水产养殖产品。据同一来源称，2021 年北美产量约 560 万尾，其中美国产量约 470 万尾，约占该地区鱼类总产量的 83%。因此，美国水产养殖产量的增加正在推动鱼疫苗市场的成长。
北美鱼疫苗市场收入及 2030 年预测（百万美元）
北美鱼疫苗市场区隔
北美鱼疫苗市场根据疫苗类型、应用、给药途径、物种和国家进行细分。
依疫苗类型，北美鱼苗市场分为灭活疫苗、减毒活疫苗、次单位疫苗、重组载体疫苗等。 2022 年，灭活疫苗细分市场占据最大市场份额。
根据应用，北美鱼疫苗市场分为细菌感染、病毒感染和寄生虫。 2022 年，细菌感染细分市场占最大市场。
根据给药途径，北美鱼苗市场分为注射疫苗、浸没疫苗和口服疫苗。 2022年，注射疫苗细分市场占据最大市场份额。
根据物种，北美鱼疫苗市场分为鲑鱼、鳟鱼、罗非鱼等。 2022 年，鲑鱼细分市场占据最大的市场。
按国家/地区划分，北美鱼疫苗市场分为美国、加拿大和墨西哥。 2022年，美国在北美鱼疫苗市场份额中占据主导地位。
Elanco Animal Health Inc.、Hipra SA、Merck & Co Inc.、Phibro Animal Health Corp、Vaxxinova International BV 和 Zoetis Inc. 是北美鱼疫苗市场上的一些领先公司。
目录
第 1 章：简介
第 2 章：执行摘要
- 北美鱼疫苗市场
第 3 章：研究方法
- 覆盖范围
- 二次研究
- 初步研究
第 4 章：北美鱼疫苗市场 - 主要产业动态
- 市场驱动因素：
- 政府发展水产养殖业的倡议
- 水产动物性食品的需求激增
- 市场限制
- 疫苗审批的严格规定
- 市场机会
- 新型鱼类疫苗的研发
- 未来的趋势
- 鱼类疫苗的技术进步
- 影响分析：
第 5 章：鱼疫苗市场 - 北美市场分析
- 鱼疫苗市场收入（千美元），2022 - 2030
第 6 章：北美鱼疫苗市场 - 2030 年收入和预测 - 按疫苗类型
- 概述
- 2022 年及 2030 年鱼疫苗市场收入份额（以疫苗类型）
- 灭活疫苗
- 减毒活疫苗
- 亚单位疫苗
- 重组载体疫苗
- 其他的
第 7 章：北美鱼疫苗市场 - 2030 年收入和预测 - 按应用
- 概述
- 2022 年及 2030 年鱼疫苗市场收入份额（按应用划分）（%）
- 细菌感染
- 病毒感染
- 寄生
第 8 章：北美鱼疫苗市场 - 2030 年收入和预测 - 按给药途径
- 概述
- 2022 年及 2030 年鱼疫苗市场收入份额（按给药途径）（%）
- 注射疫苗
- 浸没疫苗
- 口服疫苗
第 9 章：北美鱼疫苗市场 - 收入和 2030 年预测 - 按物种
- 概述
- 2022 年和 2030 年按物种分類的鱼疫苗市场收入份额 (%)
- 鲑鱼
- 鳟鱼
- 罗非鱼
- 其他的
第 10 章：北美鱼疫苗市场 - 国家分析
- 我们
- 加拿大
- 墨西哥
第 11 章：鱼疫苗市场 - 产业格局
- 概述
- 鱼疫苗市场的成长策略
- 无机成长策略
- 概述
- 有机成长策略
- 概述
第 12 章：公司简介
- Zoetis Inc
- Merck & Co Inc
- HIPRA SA
- Phibro Animal Health Corp
- Vaxxinova International BV
- Elanco Animal Health Inc
第 13 章：附录
The North America fish vaccines market was valued at US$ 160.22 million in 2022 and is expected to reach US$ 268.07 million by 2030; it is estimated to grow at a CAGR of 6.6% from 2022 to 2030.
Government Initiatives to Develop Aquaculture Industry Fuel the North America Fish Vaccines Market
Aquaculture grows exponentially due to the high demand for seafood and decreasing annual catch of wild fish. Thus, governments are taking initiatives to improve and support the growth of the aquacultural industry. Following are a few recent initiatives:
In February 2021, the Foundation for Food & Agriculture Research (FFAR) funded US$ 790,326 to create a delivery system for a vaccine that can help stop the tilapia lake virus and other diseases from spreading in the aquaculture sector.
Sea Grant Marine Aquaculture Grant Program: This nationwide competitive grant program, officially known as the "National Marine Aquaculture Initiative (NMAI)," promotes research and demonstration initiatives to advance sustainable marine aquaculture in the US.
NOAA Small Business Innovation Research (SBIR) Program: NOAA's SBIR program, which promotes small firms to use federal funds to invest in cutting-edge technologies and next-generation products and processes that can lead to commercialization, supports investments in aquaculture research and development.
Some other programs include the NOAA Fisheries Finance Program, Marine Fisheries Initiative (MARFIN), and other regional pilot projects.
In 2022, the USDA National Institute of Food and Agriculture (NIFA) announced a research investment of more than US$ 13 million to investigate new treatments and preventative measures for animal illnesses that cost the global agriculture sector billions of dollars. This included a US$ 625,000 grant to Mississippi State University to assess an antibacterial feed additive that can be used to prevent enteric septicemia in catfish in a secure and useful manner. This study will contribute to developing aquaculture producers' treatment alternatives, improving production efficiency.
Thus, an increase in government initiatives to support developments in the aquaculture industry drives the fish vaccine market growth.
North America Fish Vaccines Market Overview
The North America fish vaccines market is segmented into the US, Canada, and Mexico. The market growth in this region is attributed due to the growing aquaculture industry and surging demand for aquatic animal-derived food products. According to the National Oceanic and Atmospheric Administration, aquaculture generate ~US$ 1.5 billion annually in the US. According to the World Bank, the US produced ~448 thousand metric tons aquacultural products. As per the same source, about 5.6 million fish were produced in 2021 in North America, of which ~4.7 million is produced in the US, which is ~83% of the total region fish production. Thus, the increase in aquaculture production in the US is fueling the growth of the fish vaccines market.
North America Fish Vaccines Market Revenue and Forecast to 2030 (US$ Million)
North America Fish Vaccines Market Segmentation
The North America fish vaccines market is segmented based on vaccine type, application, route of administration, species, and country.
Based on vaccine type, the North America fish vaccines market is segmented into inactivated vaccines, live attenuated vaccines, subunit vaccines, recombinant vector vaccine, and others. The inactivated vaccines segment held the largest market share in 2022.
Based on application, the North America fish vaccines market is segmented into bacterial infection, viral infection, and parasitic. The bacterial infection segment held the largest market share in 2022.
Based on route of administration, the North America fish vaccines market is segmented into injection vaccine, immersion vaccine, and oral vaccine. The injection vaccine segment held the largest market share in 2022.
Based on species, the North America fish vaccines market is segmented into salmon, trout, tilapia, and others. The salmon segment held the largest market share in 2022.
Based on country, the North America fish vaccines market is segmented into the US, Canada, and Mexico. The US dominated the North America fish vaccines market share in 2022.
Elanco Animal Health Inc, Hipra SA, Merck & Co Inc., Phibro Animal Health Corp, Vaxxinova International BV, and Zoetis Inc. are some of the leading companies operating in the North America fish vaccines market.
Table Of Contents
1. Introduction
- 1.1 The Insight Partners Research Report Guidance
- 1.2 Market Segmentation
2. Executive Summary
- 2.1 North America Fish Vaccine Market
3. Research Methodology
- 3.1 Coverage
- 3.2 Secondary Research
- 3.3 Primary Research
4. North America Fish Vaccine Market - Key Industry Dynamics
- 4.1 Market Drivers:
- 4.1.1 Government Initiatives to Develop Aquaculture Industry
- 4.1.2 Surging Demand for Aquatic Animal-Derived Food Products
- 4.2 Market Restraints
- 4.2.1 Stringent Regulations for Approval of Vaccine
- 4.3 Market Opportunities
- 4.3.1 Development of Novel Fish Vaccine
- 4.4 Future Trends
- 4.4.1 Technological Advancements in Fish Vaccine
- 4.5 Impact Analysis:
5. Fish Vaccine Market - North America Market Analysis
- 5.1 Fish Vaccine Market Revenue (US$ Th), 2022 - 2030
6. North America Fish Vaccine Market - Revenue and Forecast to 2030 - by Vaccine Type
- 6.1 Overview
- 6.2 Fish Vaccine Market Revenue Share, by Vaccine Type, 2022 & 2030 (%)
- 6.3 Inactivated Vaccines
- 6.3.1 Overview
- 6.3.2 Inactivated Vaccines: Fish Vaccine Market - Revenue and Forecast to 2030 (US$ Thousand)
- 6.4 Live Attenuated Vaccines
- 6.4.1 Overview
- 6.4.2 Live Attenuated Vaccines: Fish Vaccine Market - Revenue and Forecast to 2030 (US$ Thousand)
- 6.5 Subunit Vaccines
- 6.5.1 Overview
- 6.5.2 Subunit Vaccines: Fish Vaccine Market - Revenue and Forecast to 2030 (US$ Thousand)
- 6.6 Recombinant Vector Vaccine
- 6.6.1 Overview
- 6.6.2 Recombinant Vector Vaccine: Fish Vaccine Market - Revenue and Forecast to 2030 (US$ Thousand)
- 6.7 Others
- 6.7.1 Overview
- 6.7.2 Others: Fish Vaccine Market - Revenue and Forecast to 2030 (US$ Thousand)
7. North America Fish Vaccine Market - Revenue and Forecast to 2030 - by Application
- 7.1 Overview
- 7.2 Fish Vaccine Market Revenue Share, by Application, 2022 & 2030 (%)
- 7.3 Bacterial Infection
- 7.3.1 Overview
- 7.3.2 Bacterial Infection: Fish Vaccine Market - Revenue and Forecast to 2030 (US$ Thousand)
- 7.4 Viral Infection
- 7.4.1 Overview
- 7.4.2 Viral Infection: Fish Vaccine Market - Revenue and Forecast to 2030 (US$ Thousand)
- 7.5 Parasitic
- 7.5.1 Overview
- 7.5.2 Parasitic: Fish Vaccine Market - Revenue and Forecast to 2030 (US$ Thousand)
8. North America Fish Vaccine Market - Revenue and Forecast to 2030 - by Route of Administration
- 8.1 Overview
- 8.2 Fish Vaccine Market Revenue Share, by Route of Administration, 2022 & 2030 (%)
- 8.3 Injection vaccine
- 8.3.1 Overview
- 8.3.2 Injection vaccine: Fish Vaccine Market - Revenue and Forecast to 2030 (US$ Thousand)
- 8.4 Immersion Vaccine
- 8.4.1 Overview
- 8.4.2 Immersion Vaccine: Fish Vaccine Market - Revenue and Forecast to 2030 (US$ Thousand)
- 8.5 Oral Vaccine
- 8.5.1 Overview
- 8.5.2 Oral Vaccine: Fish Vaccine Market - Revenue and Forecast to 2030 (US$ Thousand)
9. North America Fish Vaccine Market - Revenue and Forecast to 2030 - by Species
- 9.1 Overview
- 9.2 Fish Vaccine Market Revenue Share, by Species, 2022 & 2030 (%)
- 9.3 Salmon
- 9.3.1 Overview
- 9.3.2 Salmon: Fish Vaccine Market - Revenue and Forecast to 2030 (US$ Thousand)
- 9.4 Trout
- 9.4.1 Overview
- 9.4.2 Trout: Fish Vaccine Market - Revenue and Forecast to 2030 (US$ Thousand)
- 9.5 Tilapia
- 9.5.1 Overview
- 9.5.2 Tilapia: Fish Vaccine Market - Revenue and Forecast to 2030 (US$ Thousand)
- 9.6 Others
- 9.6.1 Overview
- 9.6.2 Others: Fish Vaccine Market - Revenue and Forecast to 2030 (US$ Thousand)
10. North America Fish Vaccine Market - Country Analysis
- 10.1 North America Fish Vaccine Market, Revenue and Forecast To 2030
- 10.1.1 Overview
- 10.1.2 North America Fish Vaccine Market, by Country
- 10.1.2.1 US
- 10.1.2.1.1 Overview
- 10.1.2.1.2 US Fish Vaccine Market Revenue and Forecast to 2030 (US$ Th)
- 10.1.2.1.3 US: Fish Vaccine Market, by Vaccine Type, 2020-2030 (US$ Thousand)
- 10.1.2.1.4 US: Fish Vaccine Market, by Route of Administration, 2020-2030 (US$ Thousand)
- 10.1.2.1.5 US: Fish Vaccine Market, by Species, 2020-2030 (US$ Thousand)
- 10.1.2.1.6 US: Fish Vaccine Market, by Application, 2020-2030 (US$ Thousand)
- 10.1.2.2 Canada
- 10.1.2.2.1 Overview
- 10.1.2.2.2 Canada Fish Vaccine Market Revenue and Forecast to 2030 (US$ Th)
- 10.1.2.2.3 Canada: Fish Vaccine Market, by Vaccine Type, 2020-2030 (US$ Thousand)
- 10.1.2.2.4 Canada: Fish Vaccine Market, by Route of Administration, 2020-2030 (US$ Thousand)
- 10.1.2.2.5 Canada: Fish Vaccine Market, by Species, 2020-2030 (US$ Thousand)
- 10.1.2.2.6 Canada: Fish Vaccine Market, by Application, 2020-2030 (US$ Thousand)
- 10.1.2.3 Mexico
- 10.1.2.3.1 Overview
- 10.1.2.3.2 Mexico Fish Vaccine Market Revenue and Forecast to 2030 (US$ Th)
- 10.1.2.3.3 Mexico: Fish Vaccine Market, by Vaccine Type, 2020-2030 (US$ Thousand)
- 10.1.2.3.4 Mexico: Fish Vaccine Market, by Route of Administration, 2020-2030 (US$ Thousand)
- 10.1.2.3.5 Mexico: Fish Vaccine Market, by Species, 2020-2030 (US$ Thousand)
- 10.1.2.3.6 Mexico: Fish Vaccine Market, by Application, 2020-2030 (US$ Thousand)
- 10.1.2.1 US
11. Fish Vaccine Market - Industry Landscape
- 11.1 Overview
- 11.2 Growth Strategies in Fish Vaccine Market
- 11.3 Inorganic Growth Strategies
- 11.3.1 Overview
- 11.4 Organic Growth Strategies
- 11.4.1 Overview
12. Company Profiles
- 12.1 Zoetis Inc
- 12.1.1 Key Facts
- 12.1.2 Business Description
- 12.1.3 Products and Services
- 12.1.4 Financial Overview
- 12.1.5 SWOT Analysis
- 12.1.6 Key Developments
- 12.2 Merck & Co Inc
- 12.2.1 Key Facts
- 12.2.2 Business Description
- 12.2.3 Products and Services
- 12.2.4 Financial Overview
- 12.2.5 SWOT Analysis
- 12.2.6 Key Developments
- 12.3 HIPRA SA
- 12.3.1 Key Facts
- 12.3.2 Business Description
- 12.3.3 Products and Services
- 12.3.4 Financial Overview
- 12.3.5 SWOT Analysis
- 12.3.6 Key Developments
- 12.4 Phibro Animal Health Corp
- 12.4.1 Key Facts
- 12.4.2 Business Description
- 12.4.3 Products and Services
- 12.4.4 Financial Overview
- 12.4.5 SWOT Analysis
- 12.4.6 Key Developments
- 12.5 Vaxxinova International BV
- 12.5.1 Key Facts
- 12.5.2 Business Description
- 12.5.3 Products and Services
- 12.5.4 Financial Overview
- 12.5.5 SWOT Analysis
- 12.5.6 Key Developments
- 12.6 Elanco Animal Health Inc
- 12.6.1 Key Facts
- 12.6.2 Business Description
- 12.6.3 Products and Services
- 12.6.4 Financial Overview
- 12.6.5 SWOT Analysis
- 12.6.6 Key Developments
13. Appendix
- 13.1 About Us
- 13.2 Glossary of Terms
List Of Tables
- Table 1. North America Fish Vaccine Market Segmentation
- Table 2. Worldwide Fish Production and Consumption in 2022
- Table 3. Major Bacterial Diseases in Fish
- Table 4. Major Viral Diseases in Fish
- Table 5. Major Parasitic Diseases in Fish
- Table 6. Atlantic Salmon Production 2020
- Table 7. US Fish Vaccine Market, by Vaccine Type - Revenue and Forecast to 2030 (US$ Thousand)
- Table 8. US Fish Vaccine Market, by Route of Administration- Revenue and Forecast to 2030 (US$ Thousand)
- Table 9. US Fish Vaccine Market, by Species- Revenue and Forecast to 2030 (US$ Thousand)
- Table 10. US Fish Vaccine Market, by Application- Revenue and Forecast to 2030 (US$ Thousand)
- Table 11. Canada Fish Vaccine Market, by Vaccine Type - Revenue and Forecast to 2030 (US$ Thousand)
- Table 12. Canada Fish Vaccine Market, by Route of Administration- Revenue and Forecast to 2030 (US$ Thousand)
- Table 13. Canada Fish Vaccine Market, by Species- Revenue and Forecast to 2030 (US$ Thousand)
- Table 14. Canada Fish Vaccine Market, by Application- Revenue and Forecast to 2030 (US$ Thousand)
- Table 15. Mexico Fish Vaccine Market, by Vaccine Type - Revenue and Forecast to 2030 (US$ Thousand)
- Table 16. Mexico Fish Vaccine Market, by Route of Administration- Revenue and Forecast to 2030 (US$ Thousand)
- Table 17. Mexico Fish Vaccine Market, by Species- Revenue and Forecast to 2030 (US$ Thousand)
- Table 18. Mexico Fish Vaccine Market, by Application- Revenue and Forecast to 2030 (US$ Thousand)
- Table 19. Recent Inorganic Growth Strategies in the Fish Vaccine Market
- Table 20. Recent Organic Growth Strategies in Fish Vaccine Market
- Table 21. Glossary of Terms, Fish Vaccine Market
List Of Figures
- Figure 1. North America Fish Vaccine Market Segmentation, By Country
- Figure 2. North America Fish Vaccine Market - Key Industry Dynamics
- Figure 3. Impact Analysis of Drivers and Restraints
- Figure 4. North America Fish Vaccine Market Revenue (US$ Th), 2022 - 2030
- Figure 5. North America Fish Vaccine Market Revenue Share, by Vaccine Type, 2022 & 2030 (%)
- Figure 6. Inactivated Vaccines: Fish Vaccine Market - Revenue and Forecast to 2030 (US$ Thousand)
- Figure 7. Live Attenuated Vaccines: Fish Vaccine Market - Revenue and Forecast to 2030 (US$ Thousand)
- Figure 8. Subunit Vaccines: Fish Vaccine Market - Revenue and Forecast to 2030 (US$ Thousand)
- Figure 9. Recombinant Vector Vaccine: Fish Vaccine Market - Revenue and Forecast to 2030 (US$ Thousand)
- Figure 10. Others: Fish Vaccine Market - Revenue and Forecast to 2030 (US$ Thousand)
- Figure 11. North America Fish Vaccine Market Revenue Share, by Application, 2022 & 2030 (%)
- Figure 12. Bacterial Infection: Fish Vaccine Market - Revenue and Forecast to 2030 (US$ Thousand)
- Figure 13. Viral Infection: Fish Vaccine Market - Revenue and Forecast to 2030 (US$ Thousand)
- Figure 14. Parasitic: Fish Vaccine Market - Revenue and Forecast to 2030 (US$ Thousand)
- Figure 15. North America Fish Vaccine Market Revenue Share, by Route of Administration, 2022 & 2030 (%)
- Figure 16. Injected: Fish Vaccine Market - Revenue and Forecast to 2030 (US$ Thousand)
- Figure 17. Immersion Vaccine: Fish Vaccine Market - Revenue and Forecast to 2030 (US$ Thousand)
- Figure 18. Oral Vaccine: Fish Vaccine Market - Revenue and Forecast to 2030 (US$ Thousand)
- Figure 19. Fish Vaccine Market Revenue Share, Species, 2022 & 2030 (%)
- Figure 20. Salmon: Fish Vaccine Market - Revenue and Forecast to 2030 (US$ Thousand)
- Figure 21. Trout: Fish Vaccine Market - Revenue and Forecast to 2030 (US$ Thousand)
- Figure 22. Tilapia: Fish Vaccine Market - Revenue and Forecast to 2030 (US$ Thousand)
- Figure 23. Others: Fish Vaccine Market - Revenue and Forecast to 2030 (US$ Thousand)
- Figure 24. North America: Fish Vaccine Market, by Key Country - Revenue (2022) (US$ Thousand)
- Figure 25. North America Fish Vaccine Market, By Key Countries, 2022 and 2030 (%)
- Figure 26. US Fish Vaccine Market Revenue and Forecast to 2030 (US$ Th)
- Figure 27. Canada Fish Vaccine Market Revenue and Forecast to 2030 (US$ Th)
- Figure 28. Mexico Fish Vaccine Market Revenue and Forecast to 2030 (US$ Th)
- Figure 29. Growth Strategies in Fish Vaccine Market
